Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aubagio
Biotech
Janssen sends off NDA for new multiple sclerosis drug ponesimod
Johnson & Johnson has handed in its NDA for its multiple sclerosis hopeful as it hopes to get in on this blockbuster market.
Ben Adams
Mar 20, 2020 8:00am
MedDay's multiple sclerosis drug a bust in phase 3
Mar 10, 2020 5:24pm
J&J multiple sclerosis hopeful tops Sanofi's Aubagio in phase 3
Sep 11, 2019 6:03pm